U.S. Capital Markets Stock News

SiTime Corporation recently reported its second quarter results with sales of US$69.49 million and a reduced net loss of US$20.18 million compared to the previous year, while also issuing third quarter revenue guidance of US$77 million to US$79 million. A key insight is that the company not only delivered substantial year-over-year revenue growth, but also indicated an expectation of further improvement in the upcoming quarter, signaling continued momentum in its business performance. We'll...

Cabot Corporation recently reported third-quarter fiscal 2025 earnings above analyst expectations, with adjusted earnings per share reaching US$1.90 despite a 9.2% year-over-year decline in net sales to US$923 million. In addition to reaffirming its fiscal 2025 guidance, Cabot has outlined plans for acquisitions and investments targeting growth areas such as batteries and conductive materials, while highlighting robust cash flow and a disciplined capital allocation approach. We'll explore...

Intellia Therapeutics recently announced that Dr. David Lebwohl, its Executive Vice President and Chief Medical Officer, will retire effective August 7, 2026, and also reported second quarter 2025 financial results showing a reduced net loss year-over-year. The decrease in net loss, both for the quarter and the first half of the year, stands out as a significant shift in the company’s financial trajectory. We’ll explore how the improved quarterly loss positions Intellia Therapeutics within...

EchoStar Corporation recently reported its second quarter 2025 financial results, revealing revenue of US$3.72 billion and a net loss of US$306.13 million, both down from the same period last year. These results show EchoStar's losses per share and revenue declines have accelerated, increasing pressure on the company's ongoing turnaround efforts. Given these wider losses and reduced revenues, we'll examine how this may impact EchoStar's investment narrative and outlook. The end of cancer?...

In recent announcements, 180 Life Sciences Corp. reported the completion of very large private placements, raising over US$425 million through common share and pre-funded warrant offerings, alongside the issuance of US$156.25 million in convertible notes to an institutional investor. A simultaneous overhaul in board composition introduced directors with extensive experience in finance, energy, and capital markets, signaling a potential evolution in the company’s operational focus and market...

Roivant Sciences recently reported first quarter 2025 earnings, revealing sales of US$2.17 million and a net loss of US$223.36 million compared to net income a year earlier, while also updating its ongoing share repurchase activities. The company completed buybacks totaling 148.63 million shares and announced plans for an additional US$500 million repurchase, signaling ongoing shareholder return efforts despite weaker financial results. We'll examine how Roivant's substantial net loss...

On August 3, 2025, Atlas Energy Solutions Inc. declared a quarterly dividend of US$0.25 per share, totaling approximately US$30.9 million, payable on August 21, 2025 to shareholders of record as of August 14, 2025, and also reported half-year results with sales of US$15.99 million, revenue of US$288.68 million, and a net loss of US$5.56 million. Despite posting a net loss for the half year, Atlas Energy Solutions continued to affirm its dividend, an outcome that can signal the company's...

Core Natural Resources, Inc. recently reported second quarter 2025 results, highlighting sales of US$1.10 billion, more than double the prior year’s figure, yet posted a net loss of US$36.56 million compared to net income a year earlier. This contrast between strong top-line growth and a swing to a substantial loss highlights ongoing operational and profitability challenges for the company. We'll explore how Core's sharp year-over-year decline in profitability, despite surging sales,...

O-I Glass, Inc. recently filed a shelf registration with the SEC covering the potential offering of 9,000,000 shares of common stock, amounting to US$114.03 million, in connection with its Employee Stock Ownership Plan (ESOP). This filing signals O-I Glass's intention to potentially issue new shares for its ESOP, an action that can impact investor perceptions by raising questions about future share supply and employee engagement initiatives. We'll examine how the ESOP-focused equity offering...

Ovintiv Inc. recently reported that its earnings have declined significantly in recent years, including a 68% fall last year and a very large decrease over the past three years. Despite these declines, analysts are forecasting rapid annual growth in Ovintiv's earnings per share over the next three years, suggesting a notable shift in sentiment about its future prospects. We’ll examine how renewed analyst optimism and the shift in earnings forecasts alter Ovintiv’s investment narrative going...

On August 1, 2025, AngloGold Ashanti plc announced a surge in net income to US$1.11 billion for the half year ended June 30, 2025, alongside higher gold production and an interim dividend of US$0.80 per share. The company's sharp increase in earnings per share, up to US$2.19 from US$0.74 a year earlier, highlights a substantial jump in profitability compared to the previous year. We'll examine how AngloGold Ashanti's strong earnings growth and dividend announcement could influence its...

Vericel Corporation recently announced its second quarter 2025 results, reporting revenue of US$63.24 million, an increase from US$52.66 million a year earlier, alongside a reduced net loss of US$553,000 and reaffirmed full-year guidance targeting MACI revenue growth and a 74% gross margin. The combination of rising revenue and reaffirmation of profitability outlook signals management's confidence in sustaining operational improvements, despite a higher net loss year-to-date. We'll examine...

Ducommun Incorporated recently announced its second quarter and six-month results for the period ended June 28, 2025, reporting sales of US$202.26 million and net income of US$12.55 million for the quarter, both higher compared to the same period last year. Net income grew at a much faster rate than sales, indicating improved profitability for Ducommun during both the quarter and year-to-date periods. We'll explore how Ducommun's higher net income growth bolsters its investment narrative and...

In its latest quarterly report released earlier this month, IES Holdings, Inc. announced that for the third quarter ended June 30, 2025, sales totaled US$890.16 million and net income was US$77.23 million, both up compared to the prior year. The company’s ongoing share buyback program, retiring nearly 0.93% of its shares by June 30, reflects a commitment to returning value to shareholders alongside rising earnings. With robust earnings growth highlighted in the latest results, we'll explore...

Schneider National, Inc. recently reported its second quarter and first half 2025 financial results, posting year-over-year increases in both sales and net income, alongside the affirmation of a quarterly cash dividend of US$0.095 per share declared by its Board of Directors. Notably, the company’s basic earnings per share from continuing operations edged higher for both reporting periods, suggesting ongoing profitability improvements heading into the latter half of the year. We’ll explore...

On August 5, 2025, LeMaitre Vascular, Inc. reported second quarter sales of US$64.23 million and net income of US$13.78 million, both up from the comparable period in 2024, and affirmed its quarterly dividend of US$0.20 per share. This combination of earnings growth and a maintained dividend signals management’s confidence in ongoing business performance and financial stability. Following stronger quarterly results and continued dividend payouts, we'll explore how robust sales and earnings...

CDW Corporation recently announced its second-quarter 2025 results, reporting US$5.98 billion in sales, up from US$5.42 billion a year ago, alongside continued share repurchases totaling 900,000 shares for US$155.82 million and a quarterly dividend affirmation of US$0.625 per share. Significantly, CDW has now completed a repurchase of 54.6 million shares, representing 36.21% of its shares, under its multi-year buyback program that began in 2014. We'll explore how CDW's accelerating share...

Hancock Whitney recently reported its second quarter 2025 results, showing a 3.2% year-over-year increase in revenue but an earnings per share of US$1.32, which fell short of analyst expectations and reflected a decline in profit margin due to higher expenses. This mixed performance highlights the company's ongoing struggle to balance revenue growth with cost management, even as revenue is forecast to outpace the average annual growth rate of the broader US banking industry over the next...

Westlake Corporation recently announced a regular dividend of US$0.53 per share for the second quarter of 2025, payable on September 4 to shareholders of record as of August 19, while also reporting a net loss of US$142 million on sales of US$2.95 billion for the quarter ended June 30, 2025. Despite this quarterly loss and no share repurchases during the period, Westlake's Board continued its dividend distribution, underscoring management's commitment to returning capital to shareholders...

Kimco Realty reported strong second quarter 2025 results, with revenue reaching US$525.18 million and net income increasing to US$162.99 million, and raised full-year earnings guidance while completing a share buyback program and affirming dividends on both common and preferred shares. The mix of improved financial performance and enhanced shareholder returns highlights both operational momentum and a commitment to capital return initiatives. We'll explore how Kimco's raised annual earnings...

Louisiana-Pacific Corporation recently reported second quarter 2025 earnings, issued updated financial guidance for the third quarter and full year, completed a share repurchase tranche, and affirmed a quarterly dividend of US$0.28 per share payable on August 29, 2025. The release highlighted a significant year-over-year decrease in net income and sales, even as the company projects growth in its siding segment and continues its dividend payments. We'll examine how the company's projected...

Neurocrine Biosciences recently reported its second quarter 2025 results, showing revenue of US$687.5 million and net income of US$107.5 million, both higher than the same quarter last year; the company also completed a share buyback and participated in Canaccord Genuity’s 45th Annual Growth Conference in Boston. The company's significant year-over-year increases in revenue and earnings signal ongoing demand for its neurology products and impact from expanded payer access and product...

Ingram Micro Holding Corporation recently reported its second quarter 2025 earnings, with sales rising to US$12.79 billion while net income fell to US$37.83 million; the company also announced a 2.6% increase in its quarterly dividend and issued new guidance for the next quarter. While sales growth outpaced last year's results, the company's earnings per share and net income showed decreases, highlighting margin pressures despite increased revenue. With the dividend increase as a focal...

Constellation Energy Corporation recently reported its second quarter 2025 results, with quarterly sales rising to US$6.10 billion and net income reaching US$839 million, alongside progress on its multi-year share buyback program and a newly affirmed quarterly dividend. Completion of repurchases amounting to over 5% of outstanding shares and quarterly earnings growth reflect notable capital allocation and operational trends at the company. We’ll examine how Constellation Energy’s strong...